Antares Pharma, Inc. logo
Antares Pharma, Inc. ATRS

Antares Pharma, Inc. Financial Ratios 2020-2011 | ATRS

Brief overview of Antares Pharma, Inc.'s financial ratios

Ratios are assessed across five available annual reports in the 2016–2020 interval.

The current valuation set is P/S 4.86x (median 6.47x), P/B 6.11x (median 10.51x). On average, this basket is 33.4% below its own five-year medians. The market values the business at a discount to recent history.

Returns on assets and capital are represented by ROE 47.2%, ROA 26.4%, ROCE 9.1%. Overall capital returns are high. The business uses resources efficiently and provides strong fundamental support for its valuation.

The time from paying for inputs to receiving cash rose from 158.7 days to 204.1 days. Cash turnover slowed.

Valuation takeaway

Antares Pharma, Inc.'s fundamental efficiency looks stronger than its current valuation relative to history. Future reports should confirm the conclusion.

Annual Financial Ratios Antares Pharma, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

12.9 -379.0 -74.8 -21.1 -14.0 -8.7 -8.7 -29.5 -36.6 -55.0

P/S

4.9 6.2 7.7 6.5 6.5 3.9 11.5 29.3 18.5 14.7

EV/EBITDA

44.0 221.3 -34.9 -24.5 -14.1 -7.8 -8.0 -27.8 -32.7 -52.0

PEG

0.0 -5.05 -1.17 -0.67 0.98 -0.18 0.13 0.49 0.37 -1.93

P/B

6.1 14.1 12.5 10.5 7.5 2.7 7.4 8.5 4.8 7.8

P/CF

108.5 -59.3 -26.7 -14.5 -16.9 -5.2 -9.6 -33.3 -30.0 -96.3

ROE %

47.18 -3.72 -16.70 -49.91 -53.82 -30.81 -85.33 -29.00 -13.20 -14.09

ROA %

26.44 -1.53 -7.38 -22.52 -36.70 -24.43 -51.11 -23.06 -11.96 -10.46

ROCE %

9.12 0.99 -27.18 -28.07 -51.95 -30.21 -78.83 -28.73 -13.07 -13.88

DSO

122.9 127.6 169.0 79.5 63.4 63.6 48.3 18.3 36.0 56.2

DIO

105.4 115.7 133.4 123.3 67.5 107.4 190.3 256.4 38.4 47.9

DPO

93.7 93.3 130.8 79.2 99.9 97.3 327.2 253.1 109.8 114.9

All numbers in USD currency

Multiples are an important financial analysis tool for the company Antares Pharma, Inc., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical instruments industry

Issuer Price % 24h Market Cap Country
BioLife Solutions BioLife Solutions
BLFS
$ 36.38 0.54 % $ 1.74 B usaUSA
Ekso Bionics Holdings Ekso Bionics Holdings
EKSO
- - $ 28.6 M usaUSA
Luminex Corporation Luminex Corporation
LMNX
- - $ 1.75 B usaUSA
Akers Biosciences, Inc. Akers Biosciences, Inc.
AKER
- -9.52 % $ 20.6 M usaUSA
CRH Medical Corporation CRH Medical Corporation
CRHM
- - $ 282 M usaUSA
The Cooper Companies The Cooper Companies
COO
$ 71.17 0.3 % $ 14.2 B usaUSA
Atrion Corporation Atrion Corporation
ATRI
- - $ 810 M usaUSA
Cantel Medical Corp. Cantel Medical Corp.
CMD
- -1.18 % $ 3.4 B usaUSA
Hill-Rom Holdings, Inc. Hill-Rom Holdings, Inc.
HRC
- -0.05 % $ 10.3 B usaUSA
Varian Medical Systems, Inc. Varian Medical Systems, Inc.
VAR
- -0.02 % $ 16.3 B usaUSA
Isoray Isoray
ISR
- 0.03 % $ 108 M usaUSA
Merit Medical Systems Merit Medical Systems
MMSI
$ 90.49 1.06 % $ 5.35 B usaUSA
AtriCure AtriCure
ATRC
$ 48.54 2.28 % $ 2.32 B usaUSA
Nephros Nephros
NEPH
$ 4.55 5.57 % $ 48.3 M usaUSA
Haemonetics Corporation Haemonetics Corporation
HAE
$ 103.96 0.03 % $ 4.9 B usaUSA
Predictive Oncology Predictive Oncology
POAI
- - $ 31.1 M usaUSA
Glaukos Corporation Glaukos Corporation
GKOS
$ 179.87 0.74 % $ 10.3 B usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
$ 7.93 0.38 % $ 352 M usaUSA
AngioDynamics AngioDynamics
ANGO
$ 15.85 0.44 % $ 658 M usaUSA
NeuroMetrix NeuroMetrix
NURO
- 5.05 % $ 9.02 M usaUSA
ICU Medical ICU Medical
ICUI
$ 175.1 0.43 % $ 4.31 B usaUSA
InfuSystem Holdings InfuSystem Holdings
INFU
$ 12.04 0.12 % $ 249 M usaUSA
iRhythm Technologies iRhythm Technologies
IRTC
$ 120.25 3.37 % $ 3.85 B usaUSA
STERIS plc STERIS plc
STE
$ 233.78 0.35 % $ 23 B usaUSA
Pro-Dex Pro-Dex
PDEX
$ 62.56 1.6 % $ 206 B usaUSA
Baxter International Baxter International
BAX
$ 26.13 0.81 % $ 13.4 B usaUSA
Repligen Corporation Repligen Corporation
RGEN
$ 176.27 0.96 % $ 9.91 M usaUSA
Pulse Biosciences Pulse Biosciences
PLSE
$ 47.57 0.04 % $ 3.21 B usaUSA
ResMed ResMed
RMD
$ 240.33 1.94 % $ 35 B usaUSA
Intuitive Surgical Intuitive Surgical
ISRG
$ 372.6 1.51 % $ 133 B usaUSA
electroCore electroCore
ECOR
$ 9.63 1.54 % $ 81.7 K usaUSA
DENTSPLY SIRONA DENTSPLY SIRONA
XRAY
$ 11.12 0.72 % $ 2.22 B usaUSA
Milestone Scientific Milestone Scientific
MLSS
$ 0.5 0.36 % $ 41 M usaUSA
Alcon Alcon
ALC
$ 72.01 0.07 % $ 35.5 B schweizSchweiz
West Pharmaceutical Services West Pharmaceutical Services
WST
$ 337.47 0.11 % $ 24.4 B usaUSA
Envista Holdings Corporation Envista Holdings Corporation
NVST
$ 27.13 0.02 % $ 4.56 B usaUSA
Masimo Corporation Masimo Corporation
MASI
- - $ 9.59 B usaUSA
Microbot Medical Microbot Medical
MBOT
$ 1.48 0.33 % $ 67.8 M israelIsrael
STAAR Surgical Company STAAR Surgical Company
STAA
$ 22.11 0.09 % $ 1.1 B usaUSA
Stereotaxis Stereotaxis
STXS
$ 1.45 0.34 % $ 132 M usaUSA
Repro Med Systems Repro Med Systems
KRMD
$ 3.23 0.94 % $ 149 M usaUSA
OraSure Technologies OraSure Technologies
OSUR
$ 3.6 0.13 % $ 265 M usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
$ 139.67 1.42 % $ 6.23 B usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
$ 80.45 0.99 % $ 1.82 B usaUSA
Becton, Dickinson and Company Becton, Dickinson and Company
BDX
$ 189.52 0.74 % $ 54.5 B usaUSA
Retractable Technologies Retractable Technologies
RVP
$ 0.73 1.14 % $ 21.9 M usaUSA
Utah Medical Products Utah Medical Products
UTMD
$ 72.77 1.35 % $ 236 M usaUSA